Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug

This publication has 35 references indexed in Scilit:

• Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy
  Catheterization and Cardiovascular Interventions, 2001
• Delayed thrombocytopenia following abciximab therapy
  International Journal of Cardiovascular Interventions, 2001
• Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
  New England Journal of Medicine, 2000
• Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.
  Journal of Clinical Investigation, 1997
• Platelet surface IgG in patients receiving infusions of Fab fragments of a chimaeric monoclonal antibody to glycoprotein IIb-IIIa
  Clinical and Experimental Immunology, 1994
• A new type of pseudothrombocytopenia: EDTA‐mediated agglutination of platelets bearing Fab fragments of a chimaeric antibody
  British Journal of Haematology, 1994
• Incidence of autoantibodies to GPIIb/IIIa in chronic autoimmune thrombocytopenic purpura may be overestimated by the MAIPA
  British Journal of Haematology, 1994
• Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
  Journal of Clinical Investigation, 1994
• Flow cytometric observations on the in vivo use of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb-IIIa
  Blood Coagulation & Fibrinolysis, 1993
• Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis.
  Journal of Clinical Investigation, 1985